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There are present in extracts of vaccine virus-infected tissues soluble 
substances which precipitate specifically when mixed under the proper 
conditions with  antivaccinal  immune  serum.  At  least  one of  these 
is destroyed by boiling in aqueous solution and it has therefore been 
designated as the "L," or heat-labile substance.  The other, resistant 
to boiling in neutral solution, is designated as the  stable  ("S")  sub- 
stance  (1).  Our recent studies have been concerned chiefly with the 
latter material and in a previous communication (2) we have reported 
the isolation from tissues infected with vaccine virus of a  heat-stable, 
alcohol-soluble substance,  presumably a  pure protein, which precipi- 
tates  specifically  with  antivaccinal  serum.  It  was  not  determined 
whether this material was antigenic. 
It has been stated that the heat-stable soluble specific substances  of vaccine 
virus were not antigenic in rabbits.  Smith (3) used a partially purified prepara- 
tion, made by boiling an extract of virus-infected testicles at pH 5.5, 8.0, and 7.0 
successively, and removing the coagulated protein at each step.  He reported that 
the injection of this material into rabbits was followed by no detectable antibody 
response and suggested  that in the manner of its action the substance resembled 
the bacterial haptenes.  Ch'en (4) employed the technic of Smith as a preliminary 
step and  then purified the active substance further by repeated precipitations 
with alcohol-ether and with alcohol and dialysis against tap water.  He obtained a 
substance which he considers to be a polysaccharide and reported that it was non- 
antigenic in rabbits.  On the other hand Craigie (5) has made preparations of the 
beat-stable substance which he partially purified by precipitation at pH 4.6.  He 
states that these substances  elicit a prompt antibody response when injected into 
rabbits  which  have previously been vaccinated.  Since  these animals  have, or 
have once had, antibodies against the substance the response is a secondary one. 
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Craigie does not report on the response of normal rabbits to injection with his 
heat-stable substance. 
The work of Craigie suggests that the heat-stable substance with 
which he is working is  antigenic since it is capable of stimulating a 
prompt secondary formation of antibodies in already immune rabbits. 
But the failure of heated, serologically active extracts to elicit anti- 
body formation in the experiments of Smith and those of Ch'en would 
seem to indicate that the substances remaining in solution were of the 
nature of bacterial haptenes.  The difficulty may be more apparent 
than real for it is well known that appreciable quantities of an antigen 
are required to initiate the formation of antibodies, while much smaller 
amounts will suffice to produce a  rapid rise of antibody titer in the 
serum of animals once immunized but in whose serum antibodies may 
be no longer detectable. 
EXPERIMENTAL 
Since we had been able to isolate from vaccine virus-infected tissues a 
heat-stable  substance,  presumably  a  protein,  which  was  evidently 
specifically related to vaccinia, it became of importance to determine 
whether or not it was antigenic.  In this communication we describe 
the response of rabbits to repeated injection with a purified prepara- 
tion of the material, and report the results of experiments designed to 
determine  the  relation  of  this  to  other  antigens  of  vaccine  virus. 
Experiments are also described which were made in an effort to learn 
the  relationship  between  antibodies  against  this  substance  and 
immunity to vaccinia. 
Materials and Methods 
1. Preparation of Heat-Stable Substance.--The heat-stable precipitating sub- 
stance was prepared as described  in our previous communication  (2).  The method 
may be summarized  as follows:  An aqueous extract of vaccine virus-infected  tissue 
was prepared and passed through a Seitz filter; the filtrate was incubated at 37°C. 
for 5 days, then boiled for 5 minutes and the coagulum which formed was dis- 
carded.  The precipitate from 25  per  cent  saturation with  ammonium sulfate 
was discarded.  The concentration of ammonium sulfate was increased to 50 per 
cent of saturation, and the resulting  precipitate was collected  and dissolved  in buf- 
fer solution (pH 7.0).  After dialysis  for 2 days against running tap water the ma- 
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The reaction of the solution was adjusted to pH 4.6 and the precipitate collected. 
This was dissolved in buffer solution at pH 7.0 and  the  active  substance  pre- 
cipitated by addition of 9 volumes of neutral  absolute  alcohol  The precipitate 
was dissolved in water and the alcohol was removed by dialysis.  For reasons  of 
economy most of the preparations  were made from extracts  of dermal vaccine 
virus. 
2.  Pure Anti-L Serum.--Serum  against  the labile substances of vaccine virus 
was prepared from antivaccinal immune serum containing both L and S precipitins. 
Antibodies against the S substances were removed from the serum by absorption 
with S antigen. 
3.  Titration of Antibody Content of Sera.--The methods of conducting agglutina- 
tion, precipitation, and complement fixation reactions have already been described 
(6).  Neutralization tests were carried out as follows: Serial tenfold dilutions of 
virus (in the form of washed elementary body suspension) were prepared in Locke 
solution.  To 0.3 cc. of each dilution an equal volume of the serum to be tested 
was added.  After a brief incubation 0.25 cc. of each mixture was inoculated intra- 
dermally in a rabbit, and the animal observed daily for the appearance of lesions. 
In order to avoid possible individual variations in susceptibility to vaccinal infec- 
tion between animals, all samples of serum from a single experimental animal were 
tested in one rabbit. 
4.  Tests of Resistance to Vaccinal Infeaion.--Mter completion of the series  of 
inoculations of antigen and collection of serum, the animala used were tested for 
resistance to infection with vaccine virus.  For this purpose they were inoculated 
intradermally with serial dilutions of vaccine virus in the form of washed elemen- 
tary bodies of vaccinia. 
5.  Housing of Animals.--In  order to guard against accidental infection with 
vaccinia  of animals  which  were  receiving  injections  of  the  pure  S  substance, 
arrangements were made to keep them in separate animal quarters.  In this way 
they were segregated from animals infected with vaccinia and were cared for by 
attendants who had no contact with vaccine virus. 
Determinations of Antigenicity in Rabbits 
Since the heat-stable  substance which we had prepared was derived 
from rabbits,  it was deemed advisable to prepare antisera in the same 
animal species in order to avoid confusion due to non-specific reactions. 
A  solution of the pure substance was prepared  and distributed  in ampoules, 
which were hermetically sealed.  These were submerged in boiling water for 90 
minutes  in order to sterilize  the  contents and  to destroy any L  antigen which 
might be present.  3 rabbits were given a series  of intraperitoneal inoculations of 
1, 2, 4, 4, and 4 cc. of the solution at weekly intervals (the solution had a precipi- 
tating titer of 1:320).  2 weeks after the last injection the rabbits were bled; the 
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The serum obtained from the rabbits following the series of injec- 
tions contained antibodies directed specifically against the heat-stable 
substance.  Inspection of Table I,  in which the  results of titrations 
are recorded, reveals that the sera precipitated in dilutions of 1:8 to 
1:32  with  extracts  of  dermal  vaccine  virus  and  agglutinated  the 
washed elementary bodies of vaccinia in  dilutions of  1 : 128  to  1 : 256. 
That the reactions did not involve products of bacterial contamination 
is demonstrated by the positive complement fixation reactions.  The 
antigen  employed in  these  tests was vaccine  virus,  cultivated  in  a 
chick embryo-Tyrode solution  medium  according  to  the  method  of 
Rivers. 
TABLE  I 
Titration  of Serum Obtained from Rabbits before and after Injection with 
S Substance 
Reaction 
Precipitation 
Agglutination 
Complement fixation 
Antigen 
Extract dermal vaccine virus 
Washed elementary bodies 
Cultured vaccine virus 
Serum 
36o 
~oree After 
--  1:32 
--  1:128 
-  ]1:16 
--  1:32 
--  1:256 
--  [1:8 
492 
3e- M- 
-I 
Absorption Experiments 
That  the  antibodies  engendered  in  response  to  injections  of  the 
stable antigen were specific for vaccine virus has been shown.  That 
they were specifically directed against the stable antigen was shown as 
follows: 
i.  Absorption  of  Serum  with  Stable Antigen.--A  portion  of  the  serum  was 
absorbed with a solution of the heat-stable antigen by the following technic.  The 
ratio of optimal precipitation was determined according to the method of Dean 
and Webb.  Serum  and antigen were mixed in the indicated proportion, incubated 
at 50°C. for 1 hour, and centrifuged at 4000  Rm.~. for 1 hour in the angle centrifuge. 
The supernatant  fluid was removed, and after remaining in the ice box overnight 
was centrifuged.  The  dear solution resulting failed to precipitate  when mixed 
either with stable antigen or with a fresh filtrate containing both L and S antigens. 
The protocol of such an experiment is given in Table II. 
This  experiment  shows that  absorption  of the  serum  with  stable 
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and that precipitins against L  antigen had not appeared in the serum 
of rabbits injected with S substance. 
TABLE  II 
Absorption of A nti-S Antibodies from Serum of Animals Injected with 
S Substance 
Serum 
361 untreated 
361  absorbed 
with  S anti- 
gen 
Antigen 
Fresh extract of dermal virus con- 
taining  L and S antigens 
Boiled extract of testicular  virus 
containing  S antigen 
Suspension of heated elementary 
bodies containing S antigen 
Fresh extract of dermal virus con- 
raining  L and S antigens 
Boiled extract  of testicular  virus 
containing S antigen 
Suspension of heated elementary 
bodies containing  S antigen 
Dilution of serum 
+ 
++ 
-t  ++!++  +  _.  _[_ 
++  +  ±  .... 
±  +  +±±l- 
i 
1 
I 
TABLE  III 
Absorption of S Antigen/tom a Mixture of L and S 
Antigen dilutions 
Antigen  solution 
Fresh extract of  dermal  virus 
containing  L and S antigens 
Fresh  extract  absorbed  with 
anti-S serum 
•  rest senun 
L  serum S 
S serumt 
Normal serum 
L  serum 
S serum 
Normal serum 
1:2.5 
++++ 
1:5  1:10  1:20  1:40  1:80 
+-t- ++  +  - 
++  -1-+ 
-F+ ++  + 
* S antibodies removed by absorption. 
t  Prepared against pure S substance. 
2.  Absorption of Antigen with Pure Serum.--A filtrate of dermal vaccine virus 
was prepared which contained both L  and S antigens.  The optimal ratio was 
determined for precipitation with anti-S serum, and to a  quantity of filtrate the 
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30 minutes, held in room temperature for 2 hours, and centrifuged at 4000 ga,.~r. 
for 1 hour in the angle centrifuge.  Mter remaining in the ice chest overnight, the 
solution was again centrifuged and the dear solution tested for the presence of the 
precipitating substance.  The results are shown in Table III. 
As is recorded in Table III, the crude skin filtrate which had been 
absorbed with our serum failed to yield a  precipitate when more of 
the same serum was added.  The addition of serum containing anti- 
bodies against the heat-labile substances gave a precipitate in almost 
as high dilutions of filtrate as before absorption.  The anti-S  serum 
had removed the heat-stable substances specifically, while leaving the 
heat-labile substances in solution. 
TABLE  IV 
Neutralization Tests witk Serum of Animals Injected with Pure S Substance 
Sexum  Highest dilution of virus causing lesion when mixed 
with undiluted serum 
360 (anti-S)  10  .4  , 10  -4 
361 (anti-S)  10  -4, 10  -4 
Normal control  10  -5, 10  ~ 
Immune control  > 10-1,  * > 10-1 
* No lesion produced by virus diluted 10  -1 when mixed with immune serum. 
Relation of Antibodies against the Heat-Stable Antigen to Vaccinal 
Immunity 
Since it had been demonstrated that injection of the S antigen into 
rabbits caused antibodies against it to appear in the serum of these 
animals,  it became of importance  to  determine whether  this  anti-S 
serum was  capable  of neutralizing the  infective capacity  of vaccine 
virus, and whether the animals themselves were resistant to inocula- 
tion with this pathogenic agent.  This was determined in the follow- 
ing manner. 
Neutralization tests were carried out as described above under Methods, as 
was also the determination of resistance  of the rabbits to infection with vaccinia. 
The results of the neutralization tests are collected in Table IV. 
Inspection of Table IV reveals the fact that the serum of the ani- 
mals injected with S substance apparently neutralized small amounts 
of  virus.  The  difference,  however,  in  the  effect on  vaccine  virus 
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questioned  whether  it  is  sufficient  to  be  taken  as  an  indication  of 
actual immunity.  Furthermore,  inoculation of minimal  amounts of 
virus gave rise to infection in the  tested animals.  The lesions pro- 
duced by a given dilution of virus appeared to be of the same severity 
in all the  animals. 
SUMMARY AND CONCLUSIONS 
We have shown that  it  is  possible  to  obtain  from extracts  of  vaccine 
virus-infected  tissues  a substance or substances,  apparently protein, 
which are serologically  active,  and which are specifically  related  to 
vaccinal infection. The present  investigation  is concerned with a 
study of their  immunological reactions. Their intraperitoneal  injec- 
tion  in rabbits  is followed  by the appearance in the serum of these 
animals of antibodies  directed  specifically  against them.  The pre- 
cipitating  capacities  of this  serum are entirely  removed after  addi- 
tion  of appropriate  quantities  of heated vaccine virus  extract,  indi- 
cating  that antibodies  against  only the heat-stable  antigens  have  been 
produced.  Further evidence of the specificity  of the antibodies  is 
gained from the reverse  experiment, that is, absorption of a virus 
extract  with the serum.  We have shown that under suitable  condi- 
tions  the serum will  remove S antigen  specifically  leaving  the labile 
substances in solution. This would apparently indicate  that they 
are  serologicaUy  distinct  although both are  vaccinal  products. 
Serum of animals injected  with the S substance and containing 
antibodies  against  it  in  high titer  is  apparently capable  of  neutralizing 
minute amounts of active  virus. The animals providing the serum 
are, however,  without demonstrable  resistance  to vaccinia. The 
significance  of the neutralizing  activity  of the serum is debatable 
because it is of a greatly different  order  of magnitude from that 
which follows infection with vaccinia. 
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